Benjamin Lockshin

2.6k total citations
22 papers, 836 citations indexed

About

Benjamin Lockshin is a scholar working on Dermatology, Immunology and Physiology. According to data from OpenAlex, Benjamin Lockshin has authored 22 papers receiving a total of 836 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Dermatology, 10 papers in Immunology and 6 papers in Physiology. Recurrent topics in Benjamin Lockshin's work include Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Allergic Rhinitis and Sensitization (5 papers). Benjamin Lockshin is often cited by papers focused on Dermatology and Skin Diseases (13 papers), Psoriasis: Treatment and Pathogenesis (10 papers) and Allergic Rhinitis and Sensitization (5 papers). Benjamin Lockshin collaborates with scholars based in United States, United Kingdom and Germany. Benjamin Lockshin's co-authors include David Main, Neal R. Boyd, Neil E. Caporaso, Peter G. Shields, Caryn Lerman, Elise D. Bowman, Janet Audrain, Yevgeniy Balagula, Joseph F. Merola and Aditya A. Joshi and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Arteriosclerosis Thrombosis and Vascular Biology and Health Psychology.

In The Last Decade

Benjamin Lockshin

20 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin Lockshin United States 10 322 264 246 148 131 22 836
Mireia del Toro Spain 17 190 0.6× 279 1.1× 132 0.5× 58 0.4× 26 0.2× 48 797
Wen Xu United States 16 110 0.3× 73 0.3× 400 1.6× 147 1.0× 18 0.1× 40 1.1k
Ken Gordon United States 9 137 0.4× 70 0.3× 551 2.2× 334 2.3× 23 0.2× 24 1.2k
Sonja Zeilinger Germany 12 229 0.7× 708 2.7× 113 0.5× 77 0.5× 19 0.1× 12 1.2k
Natascha Potoczna Switzerland 16 432 1.3× 163 0.6× 140 0.6× 145 1.0× 18 0.1× 24 1.4k
Anna Bergqvist United States 20 716 2.2× 182 0.7× 86 0.3× 14 0.1× 58 0.4× 50 1.3k
Marie‐Thérèse Walsh Ireland 16 175 0.5× 233 0.9× 92 0.4× 17 0.1× 87 0.7× 22 659
Yang Lü China 19 149 0.5× 319 1.2× 71 0.3× 10 0.1× 192 1.5× 68 943
Bingbing Fan China 13 129 0.4× 216 0.8× 113 0.5× 17 0.1× 53 0.4× 46 748

Countries citing papers authored by Benjamin Lockshin

Since Specialization
Citations

This map shows the geographic impact of Benjamin Lockshin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin Lockshin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin Lockshin more than expected).

Fields of papers citing papers by Benjamin Lockshin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin Lockshin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin Lockshin. The network helps show where Benjamin Lockshin may publish in the future.

Co-authorship network of co-authors of Benjamin Lockshin

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin Lockshin. A scholar is included among the top collaborators of Benjamin Lockshin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin Lockshin. Benjamin Lockshin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Boh, Erin, Michael C. Cameron, Brad Glick, et al.. (2025). A Review of the Safety and Efficacy of Deucravacitinib for Plaque Psoriasis: An Expert Consensus Panel. Journal of Drugs in Dermatology. 24(2). 147–155.
2.
Lockshin, Benjamin, Joseph F. Merola, Ken Gordon, et al.. (2024). The Efficacy and Safety of Bimekizumab for Plaque Psoriasis: An Expert Consensus Panel. Dermatology and Therapy. 14(2). 323–339. 4 indexed citations
3.
Alexis, Andrew, Melinda Gooderham, Shawn G. Kwatra, et al.. (2024). A Descriptive, Post Hoc Analysis of Efficacy and Safety of Risankizumab in Diverse Racial and Ethnic Patient Populations With Moderate-to-Severe Psoriasis. Dermatology and Therapy. 14(10). 2877–2887. 1 indexed citations
4.
5.
Paller, Amy S., Jonathan I. Silverberg, Michael J. Cork, et al.. (2023). Efficacy and Safety of Dupilumab in Patients With Erythrodermic Atopic Dermatitis. JAMA Dermatology. 159(3). 255–255. 8 indexed citations
6.
7.
Paller, Amy S., Elaine C. Siegfried, Michael J. Cork, et al.. (2022). Laboratory Safety from a Randomized 16-Week Phase III Study of Dupilumab in Children Aged 6 Months to 5 Years with Moderate-to-Severe Atopic Dermatitis. Pediatric Drugs. 25(1). 67–77. 4 indexed citations
8.
Blauvelt, Andrew, Kenneth B. Gordon, Patricia Lee, et al.. (2021). Efficacy, safety, usability, and acceptability of risankizumab 150 mg formulation administered by prefilled syringe or by an autoinjector for moderate to severe plaque psoriasis. Journal of Dermatological Treatment. 33(4). 2085–2093. 12 indexed citations
9.
Thibodeaux, Quinn, Kristen M. Beck, Benjamin Lockshin, et al.. (2020). Treatment of Plaque Psoriasis With an Excimer Laser Utilizing an Optimal Therapeutic UVB Dose Protocol. Journal of Drugs in Dermatology. 19(4). 349–354. 2 indexed citations
10.
Lockshin, Benjamin, et al.. (2020). A case report of uveitis secondary to dupilumab treatment for atopic dermatitis. JAAD Case Reports. 7. 98–99. 12 indexed citations
11.
Silverberg, Jonathan I., Weily Soong, Benjamin Lockshin, et al.. (2020). Dupilumab Improves Symptoms of Anxiety and Depression in Adults and Adolescents With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Three Phase 3 Trials (LIBERTY AD SOLO 1 & 2 and ADOL). Journal of Allergy and Clinical Immunology. 145(2). AB191–AB191. 2 indexed citations
12.
Lockshin, Benjamin, Yevgeniy Balagula, & Joseph F. Merola. (2018). Interleukin 17, inflammation, and cardiovascular risk in patients with psoriasis. Journal of the American Academy of Dermatology. 79(2). 345–352. 90 indexed citations
13.
14.
Aberra, Tsion, Aditya A. Joshi, Joseph B Lerman, et al.. (2016). Self-reported depression in psoriasis is associated with subclinical vascular diseases. Atherosclerosis. 251. 219–225. 20 indexed citations
15.
Naik, Haley B., Balaji Natarajan, Elena Stansky, et al.. (2015). Severity of Psoriasis Associates With Aortic Vascular Inflammation Detected by FDG PET/CT and Neutrophil Activation in a Prospective Observational Study. Arteriosclerosis Thrombosis and Vascular Biology. 35(12). 2667–2676. 132 indexed citations
16.
Mitkov, Mario, et al.. (2013). Dermatologic Side Effects of Psychotropic Medications. Psychosomatics. 55(1). 1–20. 25 indexed citations
17.
Lockshin, Benjamin, et al.. (2006). Fungating Forehead Plaque—Quiz Case. Archives of Dermatology. 142(8). 1059–64. 1 indexed citations
18.
Lockshin, Benjamin, et al.. (2004). Follicular mucinosis in a 4‐year‐old boy. International Journal of Dermatology. 43(12). 950–952. 8 indexed citations
19.
Lerman, Caryn, Neil E. Caporaso, Janet Audrain, et al.. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking.. Health Psychology. 18(1). 14–20. 211 indexed citations
20.
Lerman, Caryn, Neil E. Caporaso, Janet Audrain, et al.. (1999). Evidence suggesting the role of specific genetic factors in cigarette smoking.. Health Psychology. 18(1). 14–20. 237 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mireia del Toro Breakdown of academic impact, for papers by Wen Xu Breakdown of academic impact, for papers by Ken Gordon Breakdown of academic impact, for papers by Sonja Zeilinger Breakdown of academic impact, for papers by Natascha Potoczna Breakdown of academic impact, for papers by Anna Bergqvist Breakdown of academic impact, for papers by Marie‐Thérèse Walsh Breakdown of academic impact, for papers by Yang Lü Breakdown of academic impact, for papers by Bingbing Fan
Rankless by CCL
2026